How many stem-cell trials for Macular Degeneration & Vision are recruiting right now?
The registry lists 8 studies actively recruiting out of 44 records in total (18%), as of 2026-08-29.
Who these studies will actually take
Studies separate dry from wet disease, specify lesion characteristics on OCT and visual-acuity bands, and require surgical follow-up. Advanced geographic atrophy and good-vision early disease are both commonly excluded.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT04627428 — Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) | Phase 1, Phase 2 | Recruiting | 18 | Luxa Biotechnology, LLC | 2022-04-05 |
| NCT05445063 — Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration | Phase 1 | Recruiting | 10 | Beijing Tongren Hospital | 2022-08 |
| NCT06394232 — Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. | Phase 1, Phase 2 | Recruiting | 54 | Eyestem Research Pvt. Ltd. | 2024-06-04 |
| NCT05147701 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION | Phase 1 | Recruiting | 20 | The Foundation for Orthopaedics and Regenerative Medicine | 2022-02-01 |
| NCT00874783 — Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases | n/a | Recruiting | 120 | Hadassah Medical Organization | 2009-04 |
| NCT03011541 — Stem Cell Ophthalmology Treatment Study II | n/a | Recruiting | 500 | MD Stem Cells | 2016-01 |
| NCT01432847 — Cell Collection to Study Eye Diseases | n/a | Recruiting | 930 | National Eye Institute (NEI) | 2011-09-07 |
| NCT04339764 — Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macu | Phase 1, Phase 2 | Recruiting | 20 | National Eye Institute (NEI) | 2020-09-23 |
What recruiting does and does not mean
The status field tracks paperwork, not promise. What matters underneath it is the eligibility list, the outcome measures the sponsor committed to, and whether a site near you is actually enrolling, all of which sit on the registry record itself.
Sites sit in 15 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Astellas Institute for Regenerative Medicine — 7 registered records
- Moorfields Eye Hospital NHS Foundation Trust — 3 registered records
- National Eye Institute (NEI) — 3 registered records
- StemCells, Inc. — 2 registered records
- CHABiotech CO., Ltd — 2 registered records
- Chinese Academy of Sciences — 2 registered records
Frequently asked
How many stem-cell trials for Macular Degeneration & Vision are recruiting right now?
8 of 44 registered records (2026-08-29).
Can I join one of these trials?
That depends entirely on the written criteria — age, disease stage, prior treatment and often geography. The site's study coordinator is the only reliable source on current capacity.
Do trials charge participants?
Legitimate registered trials do not normally charge for the investigational intervention. Being asked for a large fee to enrol is a strong warning sign.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Macular Degeneration & Vision: cell-therapy evidence and registered trials
- How much does stem cell therapy for Macular Degeneration & Vision cost? (2026)
- Macular Degeneration & Vision stem cell therapy — your questions answered (2026)
- Macular Degeneration & Vision: cell-therapy evidence by therapy class